<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="pmcid: 7319644S2468-7847(20)30190-2 doi: 10.1016/j.jogoh.2020.101846101846 : Article SARS-CoV, MERS-CoV and SARS-CoV-2" exact="infections" post="in pregnancy and fetal development de Souza SilvaGuilherme Antonioguilherme.assufpe@gmail.comada"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="Abstract Recently, in China, in 2019, a new type of" exact="disease" post="has arisen caused by a new strain of coronavirus,"/>
 <result pre="geographically. For patients in general, the clinical features resulting from" exact="respiratory" post="syndromes can trigger an asymptomatic condition. However, 25 %"/>
 <result pre="understand the consequences of pregnancy and fetal development, caused by" exact="infections" post="by the SARS-CoV, MERS-CoV and SARS-CoV-2 viruses. Among the"/>
 <result pre="MERS-CoV seems to be the most dangerous for newborns, inducing" exact="high blood pressure," post="pre-eclampsia, pneumonia, acute renal failure, and multiple organ failure"/>
 <result pre="most dangerous for newborns, inducing high blood pressure, pre-eclampsia, pneumonia," exact="acute" post="renal failure, and multiple organ failure in mother. This"/>
 <result pre="dangerous for newborns, inducing high blood pressure, pre-eclampsia, pneumonia, acute" exact="renal failure," post="and multiple organ failure in mother. This also causes"/>
 <result pre="of vertical transmission for any of the coronaviruses. Thus, the" exact="limited" post="reported obstetric cases alert to the need for advanced"/>
 <result pre="for further investigation for application in clinical practice. Keywords 2019-nCoV" exact="Pregnancy" post="Pandemic SARS Newborns 1 Introduction Severe Acute Respiratory Syndrome"/>
 <result pre="clinical practice. Keywords 2019-nCoV Pregnancy Pandemic SARS Newborns 1 Introduction" exact="Severe" post="Acute Respiratory Syndrome (SARS) appeared in China in 2002"/>
 <result pre="practice. Keywords 2019-nCoV Pregnancy Pandemic SARS Newborns 1 Introduction Severe" exact="Acute" post="Respiratory Syndrome (SARS) appeared in China in 2002 as"/>
 <result pre="Keywords 2019-nCoV Pregnancy Pandemic SARS Newborns 1 Introduction Severe Acute" exact="Respiratory" post="Syndrome (SARS) appeared in China in 2002 as a"/>
 <result pre="2019-nCoV Pregnancy Pandemic SARS Newborns 1 Introduction Severe Acute Respiratory" exact="Syndrome" post="(SARS) appeared in China in 2002 as a contagious"/>
 <result pre="Syndrome (SARS) appeared in China in 2002 as a contagious" exact="disease" post="caused by Coronavirus (CoV) through contact with respiratory droplets"/>
 <result pre="a contagious disease caused by Coronavirus (CoV) through contact with" exact="respiratory" post="droplets and exposure to different fomites. Named SARS-CoV, the"/>
 <result pre="the virus triggers clinical features such as fever followed by" exact="respiratory" post="signs and symptoms that progress rapidly to the asymptomatic"/>
 <result pre="respiratory signs and symptoms that progress rapidly to the asymptomatic" exact="infection" post="with atypical pneumonia and respiratory failure [[1], [2], [3],"/>
 <result pre="and symptoms that progress rapidly to the asymptomatic infection with" exact="atypical pneumonia" post="and respiratory failure [[1], [2], [3], [4], [5]]. Saudi"/>
 <result pre="symptoms that progress rapidly to the asymptomatic infection with atypical" exact="pneumonia" post="and respiratory failure [[1], [2], [3], [4], [5]]. Saudi"/>
 <result pre="progress rapidly to the asymptomatic infection with atypical pneumonia and" exact="respiratory" post="failure [[1], [2], [3], [4], [5]]. Saudi Arabia (in"/>
 <result pre="[2], [3], [4], [5]]. Saudi Arabia (in 2014), a new" exact="respiratory" post="illness called Middle East Respiratory Syndrome (MERS) also was"/>
 <result pre="Arabia (in 2014), a new respiratory illness called Middle East" exact="Respiratory" post="Syndrome (MERS) also was attributed to CoV infection. MERS-CoV,"/>
 <result pre="(in 2014), a new respiratory illness called Middle East Respiratory" exact="Syndrome" post="(MERS) also was attributed to CoV infection. MERS-CoV, as"/>
 <result pre="CoV infection. MERS-CoV, as well as SARS-CoV, promoted a serious" exact="infection" post="that required special care in intensive care units due"/>
 <result pre="by a new strain of the coronavirus, the SARS-CoV-2 (Severe" exact="Acute" post="Respiratory Syndrome Coronavirus 2) emerged in Wuhan city. The"/>
 <result pre="a new strain of the coronavirus, the SARS-CoV-2 (Severe Acute" exact="Respiratory" post="Syndrome Coronavirus 2) emerged in Wuhan city. The new"/>
 <result pre="new strain of the coronavirus, the SARS-CoV-2 (Severe Acute Respiratory" exact="Syndrome" post="Coronavirus 2) emerged in Wuhan city. The new illness"/>
 <result pre="Coronavirus 2) emerged in Wuhan city. The new illness present" exact="respiratory" post="symptoms similar to the other two syndromes mentioned above,"/>
 <result pre="pathogenicity in humans [[8], [9], [10]]. In contrast to other" exact="viral" post="infections, such as Ebola and Influenza, SARS-CoV-2 has high"/>
 <result pre="viral infections, such as Ebola and Influenza, SARS-CoV-2 has high" exact="infectious" post="power and easy ability to spread geographically, due to"/>
 <result pre="ability to spread geographically, due to the fact that the" exact="infection" post="is asymptomatic in some cases. Although these viruses promote"/>
 <result pre="SARS-CoV and MERS-CoV in children born to mothers with the" exact="syndrome" post="[11]. New challenges emerged with the recent 2019-nCoV pandemic."/>
 <result pre="don't have epidemiological data showing significant morbidity and mortality from" exact="viral" post="diseases during pregnancy. Thus, the aim of this study"/>
 <result pre="pregnancy and fetal development, caused by SARS-CoV, MERS-CoV, and SARS-CoV-2" exact="infections" post="through studies published in the literature. 2 Methodology The"/>
 <result pre="articles fully available in the network. For final writing, a" exact="total" post="of 145 references were used, which allowed an analytical"/>
 <result pre="elaborated to achieve the proposed goal. 3 Epidemiological overview of" exact="infections" post="by SARS-CoV, MERS-CoV, and SARS-CoV-2 The SARS (Severe Acute"/>
 <result pre="of infections by SARS-CoV, MERS-CoV, and SARS-CoV-2 The SARS (Severe" exact="Acute" post="Respiratory Syndrome) epidemic caused by the SARS-CoV virus, originated"/>
 <result pre="infections by SARS-CoV, MERS-CoV, and SARS-CoV-2 The SARS (Severe Acute" exact="Respiratory" post="Syndrome) epidemic caused by the SARS-CoV virus, originated in"/>
 <result pre="in Guangdong Province, southeastern China. In the months following the" exact="primary" post="infection until its end in August 2003, there were"/>
 <result pre="Guangdong Province, southeastern China. In the months following the primary" exact="infection" post="until its end in August 2003, there were 8422"/>
 <result pre="Zhongshan University. These 12 people were responsible for spreading the" exact="infection" post="to Singapore, Vietnam, Canada, Ireland, and the United States"/>
 <result pre="Ireland, and the United States - starting the chain of" exact="infection" post="in all these countries. According to WHO estimates, the"/>
 <result pre="worldwide originated from this initial contagion [14]. The middle east" exact="respiratory" post="syndrome (MERS) became a public health issue in Asian"/>
 <result pre="originated from this initial contagion [14]. The middle east respiratory" exact="syndrome" post="(MERS) became a public health issue in Asian countries"/>
 <result pre="recorded death was in a male patient, with renal and" exact="respiratory" post="failure caused by the virus [15]. Since 2012, MERS-Cov"/>
 <result pre="these animals can be a source of spread of the" exact="infection" post="through human-animal contact [18]. According to the World Health"/>
 <result pre="Health Organization (WHO) in 2012, only 9 cases of MERS-CoV" exact="infection" post="were confirmed, including five deaths. The number of cases"/>
 <result pre="reached all of China, Asia, and finally reached the European," exact="American" post="and African continents [21]. Until the finalization of this"/>
 <result pre="of China, Asia, and finally reached the European, American and" exact="African" post="continents [21]. Until the finalization of this manuscript, this"/>
 <result pre="SARS-CoV-2 (A), SARS-CoV (B). Source: WHO, 2002-2010. 4 Characterization of" exact="viral" post="particles and their cellular interactions The SARS-CoV, MERS-CoV and"/>
 <result pre="binding to receptors in the host cell, determining host tropism." exact="Structural" post="and accessory proteins have several functions, including induction of"/>
 <result pre="dipeptidyl peptidase 4 (DPP4), also known as CD26 as the" exact="primary" post="receptor. Due to this interaction, the enzyme DDP4 began"/>
 <result pre="8b [8,44,45]. 5 Immune response to MERS-CoV, SARS-CoV and SARS-CoV-2" exact="infection" post="One of the characteristics among SARS-CoV, MERS-CoV, and SARS-CoV-2"/>
 <result pre="among SARS-CoV, MERS-CoV, and SARS-CoV-2 in infected patients is severe" exact="lymphopenia" post="[[46], [47], [48], [49], [50], [51], [52], [53]]. A"/>
 <result pre="T lymphocytes count occurs early in the course of the" exact="disease" post="and is associated with adverse results. In patients infected"/>
 <result pre="receptors by MERS-CoV [57,58]. The induction of immunosuppression throughout MERS-CoV" exact="infection" post="by promoting apoptosis of T lymphocytes was identified as"/>
 <result pre="signaling and activating T cells during the course of MERS-CoV" exact="infection" post="[60]. Ying et al. [58] observed that helper CD4+"/>
 <result pre="patients infected with MERS-CoV. Thus, it is suggested that MERS-CoV" exact="infection" post="promotes the induction of Th17 cytokines. These Th17 cytokines"/>
 <result pre="activity of recruiting neutrophils and monocytes to the site of" exact="infection" post="or inflammation and lead to the activation of other"/>
 <result pre="However, serum detection of anti-MERS-CoV antibodies occurs 14â€&quot;21 days after" exact="infection" post="[63,64]. Antibody concentrations increase over time and can last"/>
 <result pre="detection of anti-MERS-CoV antibodies occurs 14â€&quot;21 days after infection [63,64]." exact="Antibody" post="concentrations increase over time and can last for more"/>
 <result pre="long-term response is highly dependent on the severity of the" exact="infection" post="[65]. The anti-SARS-CoV antibody response can remain detectable for"/>
 <result pre="response can remain detectable for up to 24 months after" exact="infection" post="and then gradually decrease until it completely disappears 6"/>
 <result pre="then gradually decrease until it completely disappears 6 years after" exact="infection" post="[66,67]. Several HLA-A*02:01-restricted T lymphocytes that recognize epitopes of"/>
 <result pre="lymphocytes that recognize epitopes of SARS-CoV were identified in the" exact="peripheral" post="blood mononuclear cells (PBMC) of patients recovered from SARS."/>
 <result pre="cells were found in a patient who recovered from SARS-CoV" exact="infection" post="within four years after the acute phase of the"/>
 <result pre="who recovered from SARS-CoV infection within four years after the" exact="acute" post="phase of the infection. Other observations showed that three"/>
 <result pre="B lymphocytes to SARS-CoV decrease significantly after 1â€&quot;2 years of" exact="infection" post="[75]. The immunological findings to date are too preliminary"/>
 <result pre="the number of CD4+ and CD8+ T cells in the" exact="peripheral" post="blood of patiets infected with SARS-CoV-2 is significantly reduced."/>
 <result pre="al. [43], investigating 99 cases, also showed a reduction in" exact="total" post="lymphocytes (35 %) and an increase of serum IL-6"/>
 <result pre="and an increase of serum IL-6 (52 %) and C-Reactive" exact="Protein" post="(84 %) and several studies point to the importance"/>
 <result pre="the number of CD4+ and CD8+ T cells in the" exact="peripheral" post="blood of SARS-CoV-2-infected patients is reduced, but have excessive"/>
 <result pre="to 25 % of patients infected with SARS-CoV-2 [23], for" exact="acute" post="respiratory distress, pneumonia, gastrointestinal problems, liver damage, septic shock,"/>
 <result pre="25 % of patients infected with SARS-CoV-2 [23], for acute" exact="respiratory" post="distress, pneumonia, gastrointestinal problems, liver damage, septic shock, and"/>
 <result pre="[23], for acute respiratory distress, pneumonia, gastrointestinal problems, liver damage," exact="septic shock," post="and multiple organ failure, which can lead to death"/>
 <result pre="death [52,78,79]. Especially in severe cases, SARS-CoV-2 may present multifocal" exact="nodular" post="and ground-glass opacities surrounding the pulmonary lobes [80] in"/>
 <result pre="SARS-CoV-2 may present multifocal nodular and ground-glass opacities surrounding the" exact="pulmonary" post="lobes [80] in which there is an increase in"/>
 <result pre="infected pregnant women, some points should be considered, such as" exact="symptomatic" post="changes, vertical transmission to the fetus, and classification in"/>
 <result pre="is little information about SARS-CoV-2 in pregnant women. In addition," exact="infections" post="by MERS-CoV and SARS-CoV in this profile of patients"/>
 <result pre="SARS-CoV in this profile of patients are regionally limited. Thus," exact="external" post="factors such as local habits may contribute to the"/>
 <result pre="these pregnant women and for a severely compromised maternal and" exact="gestational" post="prognosis [[82], [83], [84]]. In the city of Wuhan-China,"/>
 <result pre="[83], [84]]. In the city of Wuhan-China, nine pregnant patients," exact="gestational" post="age between 36 to 38 weeks, were diagnosed with"/>
 <result pre="The most significant symptoms were fever at admission (78 %)," exact="postpartum" post="fever (68 %), myalgia (33 %), malaise (22 %),"/>
 <result pre="%), cough (44 %). Moreover, there was one case of" exact="pre-eclampsia" post="and one case of abnormal liver function. Regarding laboratory"/>
 <result pre="data were: leukocyte count (&amp;lt;9.5Â Ã—Â 109 cells/L) (78 %)," exact="lymphopenia" post="(&amp;lt;10â�¹ cell/L) (56 %), high C-reactive protein (&amp;gt; 10Â"/>
 <result pre="present in low concentrations in normal pregnant women. Meanwhile, in" exact="acute" post="morbid situations, such as infections, inflammatory processes or tissue"/>
 <result pre="values in maternal blood also in conditions such as pre-eclampsia," exact="premature birth" post="or growth restriction intra-uterine [87,88]. Assiri et al. [83]"/>
 <result pre="%) resulted in perinatal death: one pregnancy resulted in intrauterine" exact="fetal death" post="and one newborn died four hours after an emergency"/>
 <result pre="presented: shortness of breath, fever, elevated blood pressure, pre-eclampsia, pneumonia," exact="acute" post="renal failure, acute respiratory distress, and multiple organ failure."/>
 <result pre="shortness of breath, fever, elevated blood pressure, pre-eclampsia, pneumonia, acute" exact="renal failure," post="acute respiratory distress, and multiple organ failure. Similar results"/>
 <result pre="breath, fever, elevated blood pressure, pre-eclampsia, pneumonia, acute renal failure," exact="acute" post="respiratory distress, and multiple organ failure. Similar results were"/>
 <result pre="fever, elevated blood pressure, pre-eclampsia, pneumonia, acute renal failure, acute" exact="respiratory" post="distress, and multiple organ failure. Similar results were found"/>
 <result pre="[7], and Alserehi et al. [82]. The pathogenesis of the" exact="disease" post="also affects immune cells with reduced activity of NK"/>
 <result pre="malaise, and myalgia. In addition, all developed a status of" exact="lymphopenia" post="(&amp;lt;10â�¹ cell/L) and lung problems, slightly elevated lactate dehydrogenase"/>
 <result pre="points should be considered, such as complications during pregnancy and" exact="postpartum" post="[[90], [91], [92]]. The risk of viral pneumonia is"/>
 <result pre="during pregnancy and postpartum [[90], [91], [92]]. The risk of" exact="viral pneumonia" post="is significantly higher among pregnant women compared to the"/>
 <result pre="pregnancy and postpartum [[90], [91], [92]]. The risk of viral" exact="pneumonia" post="is significantly higher among pregnant women compared to the"/>
 <result pre="children died, while the remaining cases did not have SARS-CoV" exact="infection" post="[2,93]. In the United States, in 2003, a study"/>
 <result pre="showed that two out of eight people with confirmed severe" exact="disease" post="(SARS-CoV), were pregnant women. The newborn, from a mother"/>
 <result pre="tests for SARS-CoV, did not develop the disease, abnormality, or" exact="congenital" post="malformation. In this investigation, serum, blood samples in the"/>
 <result pre="were used at the time of the child-birth for diagnosis." exact="Breast" post="milk samples on days 12 and 30 postpartum were"/>
 <result pre="for diagnosis. Breast milk samples on days 12 and 30" exact="postpartum" post="were also negative for SARS-CoV. Blood, stool, and nasopharyngeal"/>
 <result pre="days 12 and 30 after delivery were also negative for" exact="viral" post="RNA. Likewise, RT-PCRs and viral cultures of cord blood"/>
 <result pre="delivery were also negative for viral RNA. Likewise, RT-PCRs and" exact="viral" post="cultures of cord blood and placental tissues were all"/>
 <result pre="obtained from the patients was also negative for SARS-CoV. No" exact="viral" post="inclusion body or particle was detected in the samples"/>
 <result pre="inclusion body or particle was detected in the samples from" exact="childbirth" post="[94]. Robertson et al. [12], reported that SARS-CoV antibodies"/>
 <result pre="al. [12], reported that SARS-CoV antibodies were detected in the" exact="breast" post="milk of an infected patient, with 19 weeks of"/>
 <result pre="gestation. However, in this case, no viruses were detected in" exact="breast" post="milk. Until now, few cases have been studied to"/>
 <result pre="Jordan, in which a fetus in the second-trimester had an" exact="acute" post="respiratory illness attributed to MERS-CoV. It was the first"/>
 <result pre="in which a fetus in the second-trimester had an acute" exact="respiratory" post="illness attributed to MERS-CoV. It was the first occurrence"/>
 <result pre="It was the first occurrence of stillbirth during a MERS-CoV" exact="infection" post="and their consequences may help the surveillance and management"/>
 <result pre="the surveillance and management of pregnant women in contexts of" exact="respiratory" post="failure [6]. Only a few reports have been published"/>
 <result pre="few reports have been published about pregnant women with an" exact="infectious" post="respiratory virus, such as MERS-CoV. A laboratory-confirmed case was"/>
 <result pre="reports have been published about pregnant women with an infectious" exact="respiratory" post="virus, such as MERS-CoV. A laboratory-confirmed case was reported"/>
 <result pre="the Republic of Korea in a woman in the 35" exact="gestational" post="weeks. She recovered and delivered a healthy baby by"/>
 <result pre="by emergency cesarean section [95]. Another case of MERS coronavirus" exact="infection" post="in a pregnant woman described in South Korea resulted"/>
 <result pre="died. Two newborns were born prematurely due to severe maternal" exact="respiratory" post="failure [99,100]. To date, there are two published cases"/>
 <result pre="perinatal results, it should be noted that there was no" exact="fetal death," post="neonatal death, or neonatal asphyxia. Four patients had premature"/>
 <result pre="it should be noted that there was no fetal death," exact="neonatal" post="death, or neonatal asphyxia. Four patients had premature labor"/>
 <result pre="noted that there was no fetal death, neonatal death, or" exact="neonatal asphyxia." post="Four patients had premature labor but under 36 gestational"/>
 <result pre="neonatal asphyxia. Four patients had premature labor but under 36" exact="gestational" post="weeks. Two of the four premature newborns had a"/>
 <result pre="detected [85]. The second report, also from China, reports the" exact="neonatal" post="prognosis of 10 children born from nine women (one"/>
 <result pre="was high and one of them died due to digestive" exact="bleeding" post="complications. The authors note that in this series of"/>
 <result pre="clinical studies have not observed vertical transmission of SARS-CoV-2 among" exact="limited" post="cases, this phenomenon still needs to be investigated more"/>
 <result pre="study, the study conducted by Schwartz [102] showed that all" exact="neonatal" post="samples tested, including in some cases placentas, were negative"/>
 <result pre="from infected pregnant women to their fetuses. A case of" exact="neonatal" post="SARS-CoV-2 infection in China with pharyngeal swabs was reported"/>
 <result pre="pregnant women to their fetuses. A case of neonatal SARS-CoV-2" exact="infection" post="in China with pharyngeal swabs was reported with a"/>
 <result pre="that there is evidence of a low risk of intrauterine" exact="infection" post="by vertical transmission of SARS-CoV-2 [104]. During the Hong"/>
 <result pre="examinations for transmission of the SARS-associated coronavirus, including RT-PCR assays," exact="viral" post="cultures, and paired serological titers. The virus was not"/>
 <result pre="treatment strategy for children with Covid-19 is based on the" exact="adult" post="experience. It is also important to highlight that the"/>
 <result pre="adult experience. It is also important to highlight that the" exact="disease" post="condition of most children is mild and, to date,"/>
 <result pre="repurposing drugs that somehow demonstrated effectiveness against MERS-CoV and/or SARS-CoV" exact="infections" post="are: Ribavirin [109], Nitazoxanide [110], Remdesivir [111] and Lopinavir,"/>
 <result pre="HCV and especially children hospitalized for the treatment of the" exact="respiratory" post="syncytial virus (RSV). According to Kim et al. [113]"/>
 <result pre="to assess the binding effect between Lopinavir, Ritonavir, and two" exact="viral" post="proteases, CEP_C30 and PLVL. This study showed that these"/>
 <result pre="is worrying, since it can trigger side effects such as" exact="anemia" post="[119]. In addition, ribavirin is contraindicated during pregnancy, due"/>
 <result pre="with humans is not significant, as observed when the Ribavirin" exact="Pregnancy" post="Registry was established in 2003 [121]. However, more information"/>
 <result pre="Chloroquine (CQ) and hydroxychloroquine (HCQ) are used to treat mainly" exact="malaria" post="and rheumatic diseases, respectively and have a very similar"/>
 <result pre="and hydroxychloroquine (HCQ) are used to treat mainly malaria and" exact="rheumatic" post="diseases, respectively and have a very similar chemical structure"/>
 <result pre="Vero E6 cells, CQ was effective to inhibit the SARS-CoV-2" exact="infection" post="[123,124]. In addition 70 % of a patient group"/>
 <result pre="group treated with HQ combined with Azithromycin had no detectable" exact="viral" post="load after 6 days of treatment [126]. However, is"/>
 <result pre="easy accessibility and previous studies of its effects in the" exact="malaria" post="treatment [103], the capacity to be ototoxic and retinotoxic"/>
 <result pre="contrast, many studies suggest that there is no increase in" exact="congenital" post="malformations associated with the use of HCQ. Evidences also"/>
 <result pre="many studies suggest that there is no increase in congenital" exact="malformations" post="associated with the use of HCQ. Evidences also support"/>
 <result pre="specific drug or vaccine is not available to treat some" exact="virus infection." post="The type 1 IFN is usually known as a"/>
 <result pre="vaccine is not available to treat some virus infection. The" exact="type 1" post="IFN is usually known as a participant to the"/>
 <result pre="known as a participant to the mammalian host defense against" exact="virus infection" post="[133]. The use of recombinant IFN inducers or IFN"/>
 <result pre="as a participant to the mammalian host defense against virus" exact="infection" post="[133]. The use of recombinant IFN inducers or IFN"/>
 <result pre="has reported that after pretreatment with IFN-I, a decrease in" exact="viral" post="protein and SARS-CoV-2 replication was observed [136]. Currently, IFN-a"/>
 <result pre="IFN [138]. However, IFN-a is used in pregnant women with" exact="thrombocytopenia" post="[139] and also was used as an alternative to"/>
 <result pre="[139] and also was used as an alternative to BCR-GLA-positive" exact="leukemia" post="treatment in pregnant women, with no evidence of increases"/>
 <result pre="women, with no evidence of increases to the rate of" exact="congenital" post="anomalies or spontaneous abortions was found [140]. Lectins are"/>
 <result pre="binding to SARS glycoprotein S is able to inhibit the" exact="viral" post="activity [142]. In addition, a study with serum from"/>
 <result pre="more frequently in infected individuals than in control patients, therefore" exact="MBL deficiency" post="can be a factor of susceptibility to infection [143]."/>
 <result pre="frequently in infected individuals than in control patients, therefore MBL" exact="deficiency" post="can be a factor of susceptibility to infection [143]."/>
 <result pre="control patients, therefore MBL deficiency can be a factor of" exact="susceptibility to" post="infection [143]. The spike glycoprotein from SARS-CoV is a"/>
 <result pre="therefore MBL deficiency can be a factor of susceptibility to" exact="infection" post="[143]. The spike glycoprotein from SARS-CoV is a promising"/>
 <result pre="red algae is known to be able to bind several" exact="viral" post="glycoproteins, including SARS-CoV spike glycoprotein and HIV glycoprotein. Griffithsin"/>
 <result pre="study using camels demonstrated effectiveness in administering vaccines with Modified" exact="Vaccinia" post="Ankara (MVA), capable of expressing the MERS-CoV S protein,"/>
 <result pre="the presence of neutralizing antibodies (NAbs) and decreased levels of" exact="infectious" post="viruses in treated camels. However, further studies are needed"/>
 <result pre="admission. This inflammatory status can promote conditions such as pre-eclampsia," exact="premature birth," post="or growth restriction intra-uterine. In fact, the fever, high"/>
 <result pre="premature birth, or growth restriction intra-uterine. In fact, the fever," exact="high blood pressure," post="pre-eclampsia, pneumonia, acute respiratory distress, and multiple organ failure,"/>
 <result pre="intra-uterine. In fact, the fever, high blood pressure, pre-eclampsia, pneumonia," exact="acute" post="respiratory distress, and multiple organ failure, have been reported"/>
 <result pre="In fact, the fever, high blood pressure, pre-eclampsia, pneumonia, acute" exact="respiratory" post="distress, and multiple organ failure, have been reported in"/>
 <result pre="distress, and multiple organ failure, have been reported in the" exact="postpartum" post="period, especially in pregnant women infected by MERS-CoV, which"/>
 <result pre="and few cases showed that the pregnancy resulted in intrauterine" exact="fetal death," post="congenital malformation (due to prematurity) or newborn death after"/>
 <result pre="cases showed that the pregnancy resulted in intrauterine fetal death," exact="congenital" post="malformation (due to prematurity) or newborn death after emergency"/>
 <result pre="death after emergency cesarean section. We believe that the coronaviruses" exact="infection" post="on pregnant can promote multiple disorders, such as shortness"/>
 <result pre="is still too early to draw conclusions. References References 1BergerA.DrostenC.DoerrH.W.StÃ¼rmerM.PreiserW.Severe" exact="acute" post="respiratory syndrome (SARS)â€&quot;paradigm of an emerging viral infectionJ Clin"/>
 <result pre="still too early to draw conclusions. References References 1BergerA.DrostenC.DoerrH.W.StÃ¼rmerM.PreiserW.Severe acute" exact="respiratory" post="syndrome (SARS)â€&quot;paradigm of an emerging viral infectionJ Clin Virol2912004132210.1016/j.jcv.2003.09.011200414675864"/>
 <result pre="too early to draw conclusions. References References 1BergerA.DrostenC.DoerrH.W.StÃ¼rmerM.PreiserW.Severe acute respiratory" exact="syndrome" post="(SARS)â€&quot;paradigm of an emerging viral infectionJ Clin Virol2912004132210.1016/j.jcv.2003.09.011200414675864 2WongS.F.ChowK.M.LeungT.N.NgW.F.NgT.K.ShekC.C.Pregnancy"/>
 <result pre="References References 1BergerA.DrostenC.DoerrH.W.StÃ¼rmerM.PreiserW.Severe acute respiratory syndrome (SARS)â€&quot;paradigm of an emerging" exact="viral" post="infectionJ Clin Virol2912004132210.1016/j.jcv.2003.09.011200414675864 2WongS.F.ChowK.M.LeungT.N.NgW.F.NgT.K.ShekC.C.Pregnancy and perinatal outcomes of women"/>
 <result pre="Clin Virol2912004132210.1016/j.jcv.2003.09.011200414675864 2WongS.F.ChowK.M.LeungT.N.NgW.F.NgT.K.ShekC.C.Pregnancy and perinatal outcomes of women with severe" exact="acute" post="respiratory syndromeAm J Obstet Gynecol1911200429229710.1016/j.ajog.2003.11.01915295381 3NgW.F.WongS.F.LamA.MarkY.F.YaoH.LeeK.C.The placentas of patients"/>
 <result pre="Virol2912004132210.1016/j.jcv.2003.09.011200414675864 2WongS.F.ChowK.M.LeungT.N.NgW.F.NgT.K.ShekC.C.Pregnancy and perinatal outcomes of women with severe acute" exact="respiratory" post="syndromeAm J Obstet Gynecol1911200429229710.1016/j.ajog.2003.11.01915295381 3NgW.F.WongS.F.LamA.MarkY.F.YaoH.LeeK.C.The placentas of patients with"/>
 <result pre="syndromeAm J Obstet Gynecol1911200429229710.1016/j.ajog.2003.11.01915295381 3NgW.F.WongS.F.LamA.MarkY.F.YaoH.LeeK.C.The placentas of patients with severe" exact="acute" post="respiratory syndrome: a pathophysiological evaluationPathology383201621021810.1080/00313020600696280 4OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.Ribavirin and interferon alfa-2a"/>
 <result pre="J Obstet Gynecol1911200429229710.1016/j.ajog.2003.11.01915295381 3NgW.F.WongS.F.LamA.MarkY.F.YaoH.LeeK.C.The placentas of patients with severe acute" exact="respiratory" post="syndrome: a pathophysiological evaluationPathology383201621021810.1080/00313020600696280 4OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.Ribavirin and interferon alfa-2a for"/>
 <result pre="pathophysiological evaluationPathology383201621021810.1080/00313020600696280 4OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.Ribavirin and interferon alfa-2a for severe Middle East" exact="respiratory" post="syndrome coronavirus infection: a retrospective cohort studyLancet Infect Dis141120141090109510.1016/S1473-3099(14)70920-X25278221"/>
 <result pre="evaluationPathology383201621021810.1080/00313020600696280 4OmraniA.S.SaadM.M.BaigK.BahloulA.Abdul-MatinM.AlaidaroosA.Y.Ribavirin and interferon alfa-2a for severe Middle East respiratory" exact="syndrome" post="coronavirus infection: a retrospective cohort studyLancet Infect Dis141120141090109510.1016/S1473-3099(14)70920-X25278221 5LaiC.C.ShihT.P.KoW.C.TangH.J.HsuehP.R.Severe"/>
 <result pre="syndrome coronavirus infection: a retrospective cohort studyLancet Infect Dis141120141090109510.1016/S1473-3099(14)70920-X25278221 5LaiC.C.ShihT.P.KoW.C.TangH.J.HsuehP.R.Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019"/>
 <result pre="coronavirus infection: a retrospective cohort studyLancet Infect Dis141120141090109510.1016/S1473-3099(14)70920-X25278221 5LaiC.C.ShihT.P.KoW.C.TangH.J.HsuehP.R.Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19):"/>
 <result pre="infection: a retrospective cohort studyLancet Infect Dis141120141090109510.1016/S1473-3099(14)70920-X25278221 5LaiC.C.ShihT.P.KoW.C.TangH.J.HsuehP.R.Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the"/>
 <result pre="the epidemic and the challengesInt J Antimicrob Agents55202010592410.1016/j.ijantimicag.2020.105924 6PayneD.C.IblanI.AlqasrawiS.NsourM.A.RhaB.TohmeR.A.Stillbirth during" exact="infection" post="with Middle East respiratory syndrome coronavirusJ Infect Dis20920141870187210.1093/infdis/jiu068524474813 7MalikA.El"/>
 <result pre="challengesInt J Antimicrob Agents55202010592410.1016/j.ijantimicag.2020.105924 6PayneD.C.IblanI.AlqasrawiS.NsourM.A.RhaB.TohmeR.A.Stillbirth during infection with Middle East" exact="respiratory" post="syndrome coronavirusJ Infect Dis20920141870187210.1093/infdis/jiu068524474813 7MalikA.El MasryK.M.RaviM.SayedF.Middle east respiratory syndrome"/>
 <result pre="J Antimicrob Agents55202010592410.1016/j.ijantimicag.2020.105924 6PayneD.C.IblanI.AlqasrawiS.NsourM.A.RhaB.TohmeR.A.Stillbirth during infection with Middle East respiratory" exact="syndrome" post="coronavirusJ Infect Dis20920141870187210.1093/infdis/jiu068524474813 7MalikA.El MasryK.M.RaviM.SayedF.Middle east respiratory syndrome coronavirus"/>
 <result pre="Middle East respiratory syndrome coronavirusJ Infect Dis20920141870187210.1093/infdis/jiu068524474813 7MalikA.El MasryK.M.RaviM.SayedF.Middle east" exact="respiratory" post="syndrome coronavirus during pregnancy, Abu Dhabi, United Arab EmiratesEmerg"/>
 <result pre="East respiratory syndrome coronavirusJ Infect Dis20920141870187210.1093/infdis/jiu068524474813 7MalikA.El MasryK.M.RaviM.SayedF.Middle east respiratory" exact="syndrome" post="coronavirus during pregnancy, Abu Dhabi, United Arab EmiratesEmerg Infect"/>
 <result pre="the 2019 novel human-pathogenic coronavirus isolated from a patient with" exact="atypical pneumonia" post="after visiting WuhanEmerg Microbes Infect91202022123610.1080/22221751.2020.171990231987001 9LiQ.GuanX.WuP.WangX.ZhouL.TongY.Early transmission dynamics in"/>
 <result pre="2019 novel human-pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting WuhanEmerg Microbes Infect91202022123610.1080/22221751.2020.171990231987001 9LiQ.GuanX.WuP.WangX.ZhouL.TongY.Early transmission dynamics in"/>
 <result pre="12RobertsonC.A.LowtherS.A.BirchT.TanC.SorhageF.StockmanL.SARS and pregnancy: a case reportEmerging Infect Dis102200434510.3201/eid1002.03073615030710 13WHOSARS (Severe" exact="acute" post="respiratory syndrome)Available from:2003https://www.who.int/ith/diseases/sars/en/ 14WHOSARS outbreak contained worldwideAvailable from:2003https://www.who.int/mediacentre/news/releases/2003/pr56/en/ 15MullerM.A.MeyerB.CormanV.M.MasriM.A.TurkestaniA.RitzD.Presence"/>
 <result pre="and pregnancy: a case reportEmerging Infect Dis102200434510.3201/eid1002.03073615030710 13WHOSARS (Severe acute" exact="respiratory" post="syndrome)Available from:2003https://www.who.int/ith/diseases/sars/en/ 14WHOSARS outbreak contained worldwideAvailable from:2003https://www.who.int/mediacentre/news/releases/2003/pr56/en/ 15MullerM.A.MeyerB.CormanV.M.MasriM.A.TurkestaniA.RitzD.Presence of"/>
 <result pre="from:2003https://www.who.int/ith/diseases/sars/en/ 14WHOSARS outbreak contained worldwideAvailable from:2003https://www.who.int/mediacentre/news/releases/2003/pr56/en/ 15MullerM.A.MeyerB.CormanV.M.MasriM.A.TurkestaniA.RitzD.Presence of Middle East" exact="respiratory" post="syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional,"/>
 <result pre="14WHOSARS outbreak contained worldwideAvailable from:2003https://www.who.int/mediacentre/news/releases/2003/pr56/en/ 15MullerM.A.MeyerB.CormanV.M.MasriM.A.TurkestaniA.RitzD.Presence of Middle East respiratory" exact="syndrome" post="coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological"/>
 <result pre="virus-encoded spike proteinMol Enzymol Drug Targets11201411010.21767/2572-5475.10001 18ChoiJ.KimMgOhYkKimYb.Progress of Middle East" exact="respiratory" post="syndrome coronavirus vaccines: a patent reviewExpert opinion on therapeutic"/>
 <result pre="spike proteinMol Enzymol Drug Targets11201411010.21767/2572-5475.10001 18ChoiJ.KimMgOhYkKimYb.Progress of Middle East respiratory" exact="syndrome" post="coronavirus vaccines: a patent reviewExpert opinion on therapeutic patentes276201772173110.1080/13543776.2017.1281248"/>
 <result pre="vaccines: a patent reviewExpert opinion on therapeutic patentes276201772173110.1080/13543776.2017.1281248 19WHOMiddle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV)Available from:2019https://www.who.int/emergencies/mers-cov/en/ 20WHOMiddle East respiratory syndrome coronavirus"/>
 <result pre="a patent reviewExpert opinion on therapeutic patentes276201772173110.1080/13543776.2017.1281248 19WHOMiddle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV)Available from:2019https://www.who.int/emergencies/mers-cov/en/ 20WHOMiddle East respiratory syndrome coronavirus (MERS-CoV)Available"/>
 <result pre="patentes276201772173110.1080/13543776.2017.1281248 19WHOMiddle East respiratory syndrome coronavirus (MERS-CoV)Available from:2019https://www.who.int/emergencies/mers-cov/en/ 20WHOMiddle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV)Available from:2019https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov) 21KeyaertsE.VijgenL.ChenL.MaesP.HedenstiernaG.Van RanstM.Inhibition of SARS-coronavirus infection"/>
 <result pre="19WHOMiddle East respiratory syndrome coronavirus (MERS-CoV)Available from:2019https://www.who.int/emergencies/mers-cov/en/ 20WHOMiddle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV)Available from:2019https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov) 21KeyaertsE.VijgenL.ChenL.MaesP.HedenstiernaG.Van RanstM.Inhibition of SARS-coronavirus infection in"/>
 <result pre="East respiratory syndrome coronavirus (MERS-CoV)Available from:2019https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov) 21KeyaertsE.VijgenL.ChenL.MaesP.HedenstiernaG.Van RanstM.Inhibition of SARS-coronavirus" exact="infection" post="in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compoundInt"/>
 <result pre="compoundInt J Infect Dis84200422322610.1016/j.ijid.2004.04.01215234326 22LipsitchM.CohenT.CooperB.RobinsJ.M.MaS.JamesL.Transmission dynamics and control of severe" exact="acute" post="respiratory syndromeScience300562720031966197010.1126/science.108661612766207 23WHOStatement on the meeting of the International"/>
 <result pre="J Infect Dis84200422322610.1016/j.ijid.2004.04.01215234326 22LipsitchM.CohenT.CooperB.RobinsJ.M.MaS.JamesL.Transmission dynamics and control of severe acute" exact="respiratory" post="syndromeScience300562720031966197010.1126/science.108661612766207 23WHOStatement on the meeting of the International health"/>
 <result pre="report of the international committee on taxonomy of viruses2012486487https://doi.org/978-0-12-384684-6 26BerminghamA.ChandiMaBrownCsAaronsE.TongC.LangrishC.Severe" exact="respiratory" post="illness caused by a novel coronavirus, in a patient"/>
 <result pre="2307880023078800 27ZakiA.M.BoheemenS.BestebroerT.M.AdmeOsterhaysFouchierR.A.M.Isolation of a novel coronavirus from a man with" exact="pneumonia" post="in Saudi ArabiaN Engl J Med3671920121814182010.1056/NEJMoa121172123075143 28MarraM.A.JonesS.J.AstellC.R.HoltR.A.Brooks-WilsonA.ButterfieldY.S.N.The genome sequence"/>
 <result pre="SARS to MERS, thrusting coronaviruses into the spotlightViruses11120195910.3390/v11010059 33BhardwajK.GuarinoL.KaoC.C.The severe" exact="acute" post="respiratory syndrome coronavirus Nsp15 protein is an endoribonuclease that"/>
 <result pre="to MERS, thrusting coronaviruses into the spotlightViruses11120195910.3390/v11010059 33BhardwajK.GuarinoL.KaoC.C.The severe acute" exact="respiratory" post="syndrome coronavirus Nsp15 protein is an endoribonuclease that prefers"/>
 <result pre="MERS, thrusting coronaviruses into the spotlightViruses11120195910.3390/v11010059 33BhardwajK.GuarinoL.KaoC.C.The severe acute respiratory" exact="syndrome" post="coronavirus Nsp15 protein is an endoribonuclease that prefers manganese"/>
 <result pre="of rational therapyCurr Mol Med57200567769710.2174/15665240577464112416305493 39LiK.Wohlford-LenaneC.L.ChannappanavarR.ParkvvJ.E.EarnestJ.T.BairT.B.Mouse-adapted MERS coronavirus causes lethal" exact="lung disease" post="in human DPP4 knockin miceProc Natl Acad Sci114152017E3119E312810.1073/pnas.161910911428348219 40ZhuZ.ZhangZ.ChenW.CaiZ.GeX.ZhuH.Predicting"/>
 <result pre="rational therapyCurr Mol Med57200567769710.2174/15665240577464112416305493 39LiK.Wohlford-LenaneC.L.ChannappanavarR.ParkvvJ.E.EarnestJ.T.BairT.B.Mouse-adapted MERS coronavirus causes lethal lung" exact="disease" post="in human DPP4 knockin miceProc Natl Acad Sci114152017E3119E312810.1073/pnas.161910911428348219 40ZhuZ.ZhangZ.ChenW.CaiZ.GeX.ZhuH.Predicting"/>
 <result pre="spike proteinInfect Genet Evol61201818318410.1016/j.meegid.2018.03.02829625240 41WuF.ZhaoS.YuB.ChenY.M.WangW.SongZ.G.A new coronavirus associated with human" exact="respiratory" post="disease in ChinaNature5797798202026526910.1038/s41586-020-2008-332015508 42GeX.Y.LiJ.L.YangX.L.ChmuraA.A.ZhuG.EpsteinJ.H.Isolation and characterization of a bat"/>
 <result pre="proteinInfect Genet Evol61201818318410.1016/j.meegid.2018.03.02829625240 41WuF.ZhaoS.YuB.ChenY.M.WangW.SongZ.G.A new coronavirus associated with human respiratory" exact="disease" post="in ChinaNature5797798202026526910.1038/s41586-020-2008-332015508 42GeX.Y.LiJ.L.YangX.L.ChmuraA.A.ZhuG.EpsteinJ.H.Isolation and characterization of a bat SARS-like"/>
 <result pre="receptorNature5037477201353553810.1038/nature1271124172901 43PengZhouYangK.L.WangZ.G.HuB.ZhangL.ZhangW.Discovery of a novel coronavirus associated with the recent" exact="pneumonia" post="outbreak in humans and its potential bat originBioRxiv0122202091495210.1101/2020.01.22.914952 44SnijderE.J.BredenbeekP.J.DobbeJ.C.ThielV.ZiebuhrJ.PoonL.L.M.Unique"/>
 <result pre="in the greater Toronto areaJAMA28920032801280910.1001/jama.289.21.JOC3088512734147 47LeeN.HuiD.WuA.ChanP.CameronP.JoyntG.A major outbreak of severe" exact="acute" post="respiratory syndrome in Hong KongN Engl J Med34820031986199412682352 48PanesarN.S.Lymphopenia"/>
 <result pre="the greater Toronto areaJAMA28920032801280910.1001/jama.289.21.JOC3088512734147 47LeeN.HuiD.WuA.ChanP.CameronP.JoyntG.A major outbreak of severe acute" exact="respiratory" post="syndrome in Hong KongN Engl J Med34820031986199412682352 48PanesarN.S.Lymphopenia in"/>
 <result pre="greater Toronto areaJAMA28920032801280910.1001/jama.289.21.JOC3088512734147 47LeeN.HuiD.WuA.ChanP.CameronP.JoyntG.A major outbreak of severe acute respiratory" exact="syndrome" post="in Hong KongN Engl J Med34820031986199412682352 48PanesarN.S.Lymphopenia in SARSLancet3612003198510.1016/S0140-6736(03)13557-X"/>
 <result pre="Hong KongN Engl J Med34820031986199412682352 48PanesarN.S.Lymphopenia in SARSLancet3612003198510.1016/S0140-6736(03)13557-X 49AjlanA.M.AhyadR.A.JamjoomL.G.AlharthyA.MadaniT.A.Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) infection: chest CT findingsAm J Roentgenol2034201478278710.2214/AJR.14.1302124918624"/>
 <result pre="KongN Engl J Med34820031986199412682352 48PanesarN.S.Lymphopenia in SARSLancet3612003198510.1016/S0140-6736(03)13557-X 49AjlanA.M.AhyadR.A.JamjoomL.G.AlharthyA.MadaniT.A.Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) infection: chest CT findingsAm J Roentgenol2034201478278710.2214/AJR.14.1302124918624 50ArabiY.M.HarthiA.HusseinJ.BouchamaA.JohaniS.HajeerA.H.Severe"/>
 <result pre="48PanesarN.S.Lymphopenia in SARSLancet3612003198510.1016/S0140-6736(03)13557-X 49AjlanA.M.AhyadR.A.JamjoomL.G.AlharthyA.MadaniT.A.Middle East respiratory syndrome coronavirus (MERS-CoV) infection:" exact="chest" post="CT findingsAm J Roentgenol2034201478278710.2214/AJR.14.1302124918624 50ArabiY.M.HarthiA.HusseinJ.BouchamaA.JohaniS.HajeerA.H.Severe neurologic syndrome associated with"/>
 <result pre="coronavirus (MERS-CoV) infection: chest CT findingsAm J Roentgenol2034201478278710.2214/AJR.14.1302124918624 50ArabiY.M.HarthiA.HusseinJ.BouchamaA.JohaniS.HajeerA.H.Severe neurologic" exact="syndrome" post="associated with Middle East respiratory syndrome corona virus (MERS-CoV)Infection434201549550110.1007/s15010-015-0720-y25600929"/>
 <result pre="findingsAm J Roentgenol2034201478278710.2214/AJR.14.1302124918624 50ArabiY.M.HarthiA.HusseinJ.BouchamaA.JohaniS.HajeerA.H.Severe neurologic syndrome associated with Middle East" exact="respiratory" post="syndrome corona virus (MERS-CoV)Infection434201549550110.1007/s15010-015-0720-y25600929 51KoJ.H.ParkG.E.LeeJ.Y.LeeJ.Y.ChoS.Y.HaY.E.Predictive factors for pneumonia development"/>
 <result pre="J Roentgenol2034201478278710.2214/AJR.14.1302124918624 50ArabiY.M.HarthiA.HusseinJ.BouchamaA.JohaniS.HajeerA.H.Severe neurologic syndrome associated with Middle East respiratory" exact="syndrome" post="corona virus (MERS-CoV)Infection434201549550110.1007/s15010-015-0720-y25600929 51KoJ.H.ParkG.E.LeeJ.Y.LeeJ.Y.ChoS.Y.HaY.E.Predictive factors for pneumonia development and"/>
 <result pre="Middle East respiratory syndrome corona virus (MERS-CoV)Infection434201549550110.1007/s15010-015-0720-y25600929 51KoJ.H.ParkG.E.LeeJ.Y.LeeJ.Y.ChoS.Y.HaY.E.Predictive factors for" exact="pneumonia" post="development and progression to respiratory failure in MERS-CoV infected"/>
 <result pre="virus (MERS-CoV)Infection434201549550110.1007/s15010-015-0720-y25600929 51KoJ.H.ParkG.E.LeeJ.Y.LeeJ.Y.ChoS.Y.HaY.E.Predictive factors for pneumonia development and progression to" exact="respiratory" post="failure in MERS-CoV infected patientsJ Infect735201646847510.1016/j.jinf.2016.08.00527519621 52XuL.LiuJ.LuM.YangD.ZhengX.Liver damage during"/>
 <result pre="follow-up surveysChinese J Cell Mol Immunol2032004322324 56JossetL.MenacheryV.D.GrajinskiL.E.AgnihothramS.SovaP.CarterV.S.Cell host response to" exact="infection" post="with novel human coronavirus EMC predicts potential antivirals and"/>
 <result pre="important differences with SARS coronavirusMBio432013e001651310.1128/mBio.00165-1323631916 57ChuH.ZhouJ.WongB.H.Y.LiC.ChengZ.S.LinX.Productive repliC.aTion of Middle East" exact="respiratory" post="syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune"/>
 <result pre="differences with SARS coronavirusMBio432013e001651310.1128/mBio.00165-1323631916 57ChuH.ZhouJ.WongB.H.Y.LiC.ChengZ.S.LinX.Productive repliC.aTion of Middle East respiratory" exact="syndrome" post="coronavirus in monocyte-derived dendritic cells modulates innate immune responseVirology454201419720510.1016/j.virol.2014.02.01824725946"/>
 <result pre="monocyte-derived dendritic cells modulates innate immune responseVirology454201419720510.1016/j.virol.2014.02.01824725946 58YingT.LiW.DimitrovD.S.Discovery of T-cell" exact="infection" post="and apoptosis by Middle East respiratory syndrome coronavirusJ Infect"/>
 <result pre="responseVirology454201419720510.1016/j.virol.2014.02.01824725946 58YingT.LiW.DimitrovD.S.Discovery of T-cell infection and apoptosis by Middle East" exact="respiratory" post="syndrome coronavirusJ Infect Dis2136201687787910.1093/infdis/jiv38126203059 59IshiiT.OhnumaK.MurakamiA.TakasawaN.KobayashiS.DanN.H.CD26-mediated signaling for T cell"/>
 <result pre="58YingT.LiW.DimitrovD.S.Discovery of T-cell infection and apoptosis by Middle East respiratory" exact="syndrome" post="coronavirusJ Infect Dis2136201687787910.1093/infdis/jiv38126203059 59IshiiT.OhnumaK.MurakamiA.TakasawaN.KobayashiS.DanN.H.CD26-mediated signaling for T cell activation"/>
 <result pre="Sci98212001121381214310.1073/pnas.21143909811593028 60ManniM.L.RobinsonK.M.AlcornJ.F.A tale of two cytokines: IL-17 and IL-22 in" exact="asthma" post="and infectionExpert Rev Respir Med812014254210.1586/17476348.2014.85416724325586 61MahallawiW.H.KhabourO.F.ZhangQ.MakhdoumH.M.SulimanB.A.MERS-CoV infection in humans"/>
 <result pre="and IL-22 in asthma and infectionExpert Rev Respir Med812014254210.1586/17476348.2014.85416724325586 61MahallawiW.H.KhabourO.F.ZhangQ.MakhdoumH.M.SulimanB.A.MERS-CoV" exact="infection" post="in humans is associated with a pro-inflammatory Th1 and"/>
 <result pre="inflammationEmerg Microbes Infect2120131510.1038/emi.2013.58 63ParkW.B.RAPMPereraChoeP.G.LauE.H.Y.ChoiS.J.ChunJ.Y.Kinetics of serologic responses to MERS coronavirus" exact="infection" post="in humans, South KoreaEmerging Infect Dis21122015218610.3201/eid2112.15142126583829 64CormanV.M.AlbarrakA.M.OmraniA.S.AlbarrakA.M.FarahM.E.AlmasriM.Viral shedding and"/>
 <result pre="shedding and antibody response in 37 patients with Middle East" exact="respiratory" post="syndrome coronavirus infectionClin Infect Dis624201647748310.1093/cid/civ95126565003 65AlshukairiA.N.KhalidI.K.AhmedW.A.DadaA.M.BayumiD.T.MÃ¡licaL.S.Antibody response and disease"/>
 <result pre="and antibody response in 37 patients with Middle East respiratory" exact="syndrome" post="coronavirus infectionClin Infect Dis624201647748310.1093/cid/civ95126565003 65AlshukairiA.N.KhalidI.K.AhmedW.A.DadaA.M.BayumiD.T.MÃ¡licaL.S.Antibody response and disease severity"/>
 <result pre="East respiratory syndrome coronavirus infectionClin Infect Dis624201647748310.1093/cid/civ95126565003 65AlshukairiA.N.KhalidI.K.AhmedW.A.DadaA.M.BayumiD.T.MÃ¡licaL.S.Antibody response and" exact="disease" post="severity in healthcare worker MERS survivorsEmerging Infect Dis2262016111310.3201/eid2206.160010 66LiuW.FontanetA.ZhangP.H.ZhanL.XinZ.T.BarilL.Two-year"/>
 <result pre="study of the humoral immune response of patients with severe" exact="acute" post="respiratory syndromeJ Infect Dis1936200679279510.1086/50046916479513 67TangF.QuanY.XinZ.T.WrammertJ.MaM.J.LvH.Lack of peripheral memory B"/>
 <result pre="of the humoral immune response of patients with severe acute" exact="respiratory" post="syndromeJ Infect Dis1936200679279510.1086/50046916479513 67TangF.QuanY.XinZ.T.WrammertJ.MaM.J.LvH.Lack of peripheral memory B cell"/>
 <result pre="patients with severe acute respiratory syndromeJ Infect Dis1936200679279510.1086/50046916479513 67TangF.QuanY.XinZ.T.WrammertJ.MaM.J.LvH.Lack of" exact="peripheral" post="memory B cell responses in recovered patients with severe"/>
 <result pre="peripheral memory B cell responses in recovered patients with severe" exact="acute" post="respiratory syndrome: a six-year follow-up studyJ Immunol1861220117264726810.4049/jimmunol.090349021576510 68WangY.D.SinW.Y.F.XuG.B.YangH.H.WongT.Y.PangX.W.T-cell epitopes"/>
 <result pre="memory B cell responses in recovered patients with severe acute" exact="respiratory" post="syndrome: a six-year follow-up studyJ Immunol1861220117264726810.4049/jimmunol.090349021576510 68WangY.D.SinW.Y.F.XuG.B.YangH.H.WongT.Y.PangX.W.T-cell epitopes in"/>
 <result pre="syndrome: a six-year follow-up studyJ Immunol1861220117264726810.4049/jimmunol.090349021576510 68WangY.D.SinW.Y.F.XuG.B.YangH.H.WongT.Y.PangX.W.T-cell epitopes in severe" exact="acute" post="respiratory syndrome (SARS) coronavirus spike protein elicit a specific"/>
 <result pre="a six-year follow-up studyJ Immunol1861220117264726810.4049/jimmunol.090349021576510 68WangY.D.SinW.Y.F.XuG.B.YangH.H.WongT.Y.PangX.W.T-cell epitopes in severe acute" exact="respiratory" post="syndrome (SARS) coronavirus spike protein elicit a specific T-cell"/>
 <result pre="six-year follow-up studyJ Immunol1861220117264726810.4049/jimmunol.090349021576510 68WangY.D.SinW.Y.F.XuG.B.YangH.H.WongT.Y.PangX.W.T-cell epitopes in severe acute respiratory" exact="syndrome" post="(SARS) coronavirus spike protein elicit a specific T-cell immune"/>
 <result pre="patients who recover from SARSJ Virol781120045612561810.1128/JVI.78.11.5612-5618.200415140958 69XuX.GaoX.M.Immunological responses against SARS-coronavirus" exact="infection" post="in humansCell Mol Immunol12200411912216212898 70YangL.T.PengH.ZhuZ.L.LiG.HuangZ.T.ZhaoZ.X.Long-lived effector/central memory T-cell responses"/>
 <result pre="humansCell Mol Immunol12200411912216212898 70YangL.T.PengH.ZhuZ.L.LiG.HuangZ.T.ZhaoZ.X.Long-lived effector/central memory T-cell responses to severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS"/>
 <result pre="Mol Immunol12200411912216212898 70YangL.T.PengH.ZhuZ.L.LiG.HuangZ.T.ZhaoZ.X.Long-lived effector/central memory T-cell responses to severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patientsClin"/>
 <result pre="Immunol12200411912216212898 70YangL.T.PengH.ZhuZ.L.LiG.HuangZ.T.ZhaoZ.X.Long-lived effector/central memory T-cell responses to severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) S antigen in recovered SARS patientsClin Immunol1202200617117810.1016/j.clim.2006.05.00216781892"/>
 <result pre="coronavirus infectionVirology3682200731732110.1016/j.virol.2007.07.01517692881 72ChenH.HouJ.JiangX.MaS.MengM.WangB.Response of memory CD8+ T cells to severe" exact="acute" post="respiratory syndrome (SARS) coronavirus in recovered SARS patients and"/>
 <result pre="infectionVirology3682200731732110.1016/j.virol.2007.07.01517692881 72ChenH.HouJ.JiangX.MaS.MengM.WangB.Response of memory CD8+ T cells to severe acute" exact="respiratory" post="syndrome (SARS) coronavirus in recovered SARS patients and healthy"/>
 <result pre="72ChenH.HouJ.JiangX.MaS.MengM.WangB.Response of memory CD8+ T cells to severe acute respiratory" exact="syndrome" post="(SARS) coronavirus in recovered SARS patients and healthy individualsJ"/>
 <result pre="recovered SARS patients and healthy individualsJ Immunol1751200559159810.4049/jimmunol.175.1.59115972696 73OpenshawP.J.M.What does the" exact="peripheral" post="blood tell you in SARS?Clin Exp Immunol13612004111210.1111/j.1365-2249.2004.02448.x15030507 74YangL.PengH.ZhuZ.LiG.HuangZ.ZhaoZ.Persistent memory"/>
 <result pre="74YangL.PengH.ZhuZ.LiG.HuangZ.ZhaoZ.Persistent memory CD4+ and CD8+ T-cell responses in recovered severe" exact="acute" post="respiratory syndrome (SARS) patients to SARS coronavirus M antigenJ"/>
 <result pre="memory CD4+ and CD8+ T-cell responses in recovered severe acute" exact="respiratory" post="syndrome (SARS) patients to SARS coronavirus M antigenJ Gen"/>
 <result pre="CD4+ and CD8+ T-cell responses in recovered severe acute respiratory" exact="syndrome" post="(SARS) patients to SARS coronavirus M antigenJ Gen Virol88102007274010.1099/vir.0.82839-017872527"/>
 <result pre="and evolution of coronavirus spike proteinsAnnu Rev Virol3201623726110.1146/annurev-virology-110615-04230127578435 78HuiD.S.AzharE.I.KimY.J.MemishZ.A.OhM.D.ZumlaA.Middle East" exact="respiratory" post="syndrome coronavirus: risk factors and determinants of primary, household,"/>
 <result pre="evolution of coronavirus spike proteinsAnnu Rev Virol3201623726110.1146/annurev-virology-110615-04230127578435 78HuiD.S.AzharE.I.KimY.J.MemishZ.A.OhM.D.ZumlaA.Middle East respiratory" exact="syndrome" post="coronavirus: risk factors and determinants of primary, household, and"/>
 <result pre="primary, household, and nosocomial transmissionLancet Infect Dis1882018e217e22710.1016/S1473-3099(18)30127-029680581 79European Centre for" exact="Disease" post="Prevention and Control (ECDC)Rapid risk assessment: severe respiratory disease"/>
 <result pre="Centre for Disease Prevention and Control (ECDC)Rapid risk assessment: severe" exact="respiratory" post="disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV)22nd"/>
 <result pre="for Disease Prevention and Control (ECDC)Rapid risk assessment: severe respiratory" exact="disease" post="associated with Middle East respiratory syndrome coronavirus (MERS-CoV)22nd update2018"/>
 <result pre="(ECDC)Rapid risk assessment: severe respiratory disease associated with Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV)22nd update2018 80KongW.AgarwalP.P.Chest imaging apperance of COVID-19"/>
 <result pre="risk assessment: severe respiratory disease associated with Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV)22nd update2018 80KongW.AgarwalP.P.Chest imaging apperance of COVID-19 infectionRadiol"/>
 <result pre="imaging apperance of COVID-19 infectionRadiol Cardio Imag212020e20002810.1148/ryct.2020200028 81SantosM.L.O.Ground-glass opacity in" exact="diffuse" post="lung diseases: high-resolution computed tomography-pathology correlationRadiol Bras366200310.1590/S0100-39842003000600003 82AlserehiH.WaliG.AlshukairiA.AlraddadiB.Impact of"/>
 <result pre="diseases: high-resolution computed tomography-pathology correlationRadiol Bras366200310.1590/S0100-39842003000600003 82AlserehiH.WaliG.AlshukairiA.AlraddadiB.Impact of Middle East" exact="Respiratory" post="Syndrome coronavirus (MERSâ€�CoV) on pregnancy and perinatal outcomeBMC Infect"/>
 <result pre="high-resolution computed tomography-pathology correlationRadiol Bras366200310.1590/S0100-39842003000600003 82AlserehiH.WaliG.AlshukairiA.AlraddadiB.Impact of Middle East Respiratory" exact="Syndrome" post="coronavirus (MERSâ€�CoV) on pregnancy and perinatal outcomeBMC Infect Dis16201610510.1186/s12879-016-1437-y26936356"/>
 <result pre="(MERSâ€�CoV) on pregnancy and perinatal outcomeBMC Infect Dis16201610510.1186/s12879-016-1437-y26936356 83AssiriA.AbediG.R.MasriM.A.SaeedA.B.GerberS.I.WatsonJ.T.Middle East" exact="Respiratory" post="syndrome coronavirus infection during pregnancy: a report of 5"/>
 <result pre="on pregnancy and perinatal outcomeBMC Infect Dis16201610510.1186/s12879-016-1437-y26936356 83AssiriA.AbediG.R.MasriM.A.SaeedA.B.GerberS.I.WatsonJ.T.Middle East Respiratory" exact="syndrome" post="coronavirus infection during pregnancy: a report of 5 cases"/>
 <result pre="and perinatal outcomeBMC Infect Dis16201610510.1186/s12879-016-1437-y26936356 83AssiriA.AbediG.R.MasriM.A.SaeedA.B.GerberS.I.WatsonJ.T.Middle East Respiratory syndrome coronavirus" exact="infection" post="during pregnancy: a report of 5 cases from Saudi"/>
 <result pre="of 5 cases from Saudi ArabiaClin Infect Dis637201695195310.1093/cid/ciw41227358348 84CDCCenters for" exact="Disease" post="Control and PreventionUpdate: severe respiratory illness associated with Middle"/>
 <result pre="ArabiaClin Infect Dis637201695195310.1093/cid/ciw41227358348 84CDCCenters for Disease Control and PreventionUpdate: severe" exact="respiratory" post="illness associated with Middle East Respiratory Syndrome Coronavirus (MERS-CoV)"/>
 <result pre="Control and PreventionUpdate: severe respiratory illness associated with Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV) worldwide, 2012-2013MMWR Morb Mortal Wkly Rep6223201348048323760190"/>
 <result pre="and PreventionUpdate: severe respiratory illness associated with Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV) worldwide, 2012-2013MMWR Morb Mortal Wkly Rep6223201348048323760190 85ChenH.GuoJ.WangC.LuoF.YuX.ZhangW.Clinical"/>
 <result pre="Rep6223201348048323760190 85ChenH.GuoJ.WangC.LuoF.YuX.ZhangW.Clinical characteristics and intrauterine vertical transmission potential of COVID-19" exact="infection" post="in nine pregnant women: a retrospective review of medical"/>
 <result pre="protein levels during first trimester of pregnancy are indicative of" exact="preeclampsia" post="and intrauterine growth restrictionJ Reprod Immunol592003293710.1016/S0165-0378(02)00085-212892901 89RobinsonD.P.KleinS.L.Pregnancy and pregnancy-associated"/>
 <result pre="Reprod Immunol592003293710.1016/S0165-0378(02)00085-212892901 89RobinsonD.P.KleinS.L.Pregnancy and pregnancy-associated hormones alter immune responses and" exact="disease" post="pathogenesisHorm Behav62201226327110.1016/j.yhbeh.2012.02.02322406114 90LeeC.H.HuangN.ChangH.J.HsuY.J.WangM.C.ChouY.J.The immediate effects of the severe acute"/>
 <result pre="and disease pathogenesisHorm Behav62201226327110.1016/j.yhbeh.2012.02.02322406114 90LeeC.H.HuangN.ChangH.J.HsuY.J.WangM.C.ChouY.J.The immediate effects of the severe" exact="acute" post="respiratory syndrome (SARS) epidemic on childbirth in TaiwanBMC Public"/>
 <result pre="disease pathogenesisHorm Behav62201226327110.1016/j.yhbeh.2012.02.02322406114 90LeeC.H.HuangN.ChangH.J.HsuY.J.WangM.C.ChouY.J.The immediate effects of the severe acute" exact="respiratory" post="syndrome (SARS) epidemic on childbirth in TaiwanBMC Public Health51200510.1186/1471-2458-5-30"/>
 <result pre="pathogenesisHorm Behav62201226327110.1016/j.yhbeh.2012.02.02322406114 90LeeC.H.HuangN.ChangH.J.HsuY.J.WangM.C.ChouY.J.The immediate effects of the severe acute respiratory" exact="syndrome" post="(SARS) epidemic on childbirth in TaiwanBMC Public Health51200510.1186/1471-2458-5-30 91LeeD.T.S.SahotaD.LeungT.N.YipA.S.K.LeeF.F.Y.ChungT.K.H.Psychological"/>
 <result pre="effects of the severe acute respiratory syndrome (SARS) epidemic on" exact="childbirth" post="in TaiwanBMC Public Health51200510.1186/1471-2458-5-30 91LeeD.T.S.SahotaD.LeungT.N.YipA.S.K.LeeF.F.Y.ChungT.K.H.Psychological responses of pregnant women"/>
 <result pre="TaiwanBMC Public Health51200510.1186/1471-2458-5-30 91LeeD.T.S.SahotaD.LeungT.N.YipA.S.K.LeeF.F.Y.ChungT.K.H.Psychological responses of pregnant women to an" exact="infectious" post="outbreak: a case-control study of the 2003 SARS outbreak"/>
 <result pre="course and outcomes of pregnant and non-pregnant women with severe" exact="acute" post="respiratory syndromeBjog Int J Obstet Gynaecol1118200477177410.1111/j.1471-0528.2004.00199.x 93ZhangJ.P.WangY.H.ChenL.N.ZhangR.XieY.F.Clinical analysis of"/>
 <result pre="and outcomes of pregnant and non-pregnant women with severe acute" exact="respiratory" post="syndromeBjog Int J Obstet Gynaecol1118200477177410.1111/j.1471-0528.2004.00199.x 93ZhangJ.P.WangY.H.ChenL.N.ZhangR.XieY.F.Clinical analysis of pregnancy"/>
 <result pre="analysis of pregnancy in second and third trimesters complicated severe" exact="acute" post="respiratory syndromeZhonghua Fu Chan Ke Za Zhi388200351652014521763 94StockmanL.J.LowtherS.A.CoyK.SawJ.ParasharU.D.SARS during"/>
 <result pre="of pregnancy in second and third trimesters complicated severe acute" exact="respiratory" post="syndromeZhonghua Fu Chan Ke Za Zhi388200351652014521763 94StockmanL.J.LowtherS.A.CoyK.SawJ.ParasharU.D.SARS during pregnancy,"/>
 <result pre="95ParkM.H.KimH.R.ChoiD.H.SungJ.H.KimJ.H.Emergency cesarean section in an epidemic of the middle east" exact="respiratory" post="syndrome: a case reportKorean J Anesthesiol693201628710.4097/kjae.2016.69.3.28727274377 96RacicotK.KwonJ.-Y.AlsoP.SilasiM.MorG.Understanding the complexity"/>
 <result pre="of the immune system during pregnancyAm J Reprod Immunol.72201410711610.1111/aji.1228924995526 97JeongS.Y.SungS.I.SungJ.H.AhnS.Y.KangE.S.ChangY.S.MERS-CoV" exact="Infection" post="in a pregnant woman in KoreaJ Korean Med Sci321020171717172010.3346/jkms.2017.32.10.171728875620"/>
 <result pre="pregnant woman in KoreaJ Korean Med Sci321020171717172010.3346/jkms.2017.32.10.171728875620 98RacicotK.MorG.Risks associated with" exact="viral" post="infections during pregnancyJ Clin Invest127520171591159910.1172/JCI8749028459427 99AlfarajS.H.Al-TawfiqJ.A.MemishZ.A.Middle East Respiratory Syndrome"/>
 <result pre="woman in KoreaJ Korean Med Sci321020171717172010.3346/jkms.2017.32.10.171728875620 98RacicotK.MorG.Risks associated with viral" exact="infections" post="during pregnancyJ Clin Invest127520171591159910.1172/JCI8749028459427 99AlfarajS.H.Al-TawfiqJ.A.MemishZ.A.Middle East Respiratory Syndrome Coronavirus"/>
 <result pre="associated with viral infections during pregnancyJ Clin Invest127520171591159910.1172/JCI8749028459427 99AlfarajS.H.Al-TawfiqJ.A.MemishZ.A.Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV) infection during pregnancy: report of two"/>
 <result pre="with viral infections during pregnancyJ Clin Invest127520171591159910.1172/JCI8749028459427 99AlfarajS.H.Al-TawfiqJ.A.MemishZ.A.Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV) infection during pregnancy: report of two cases"/>
 <result pre="during pregnancyJ Clin Invest127520171591159910.1172/JCI8749028459427 99AlfarajS.H.Al-TawfiqJ.A.MemishZ.A.Middle East Respiratory Syndrome Coronavirus (MERS-CoV)" exact="infection" post="during pregnancy: report of two cases &amp;amp; review of"/>
 <result pre="their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus" exact="infections" post="and pregnancy outcomesArch Pathol Lab Med202010.5858/arpa.2020-0901-SA0: null 103WangS.GuoL.ChenL.LiuW.CaoY.ZhangJ.A case"/>
 <result pre="pregnancy outcomesArch Pathol Lab Med202010.5858/arpa.2020-0901-SA0: null 103WangS.GuoL.ChenL.LiuW.CaoY.ZhangJ.A case report of" exact="neonatal" post="COVID-19 infection in ChinaClin Infect Dis202010.1093/cid/ciaa225 104FanC.LeiD.FrangC.LiC.WangM.LiuY.Perinatal Transmission of"/>
 <result pre="Pathol Lab Med202010.5858/arpa.2020-0901-SA0: null 103WangS.GuoL.ChenL.LiuW.CaoY.ZhangJ.A case report of neonatal COVID-19" exact="infection" post="in ChinaClin Infect Dis202010.1093/cid/ciaa225 104FanC.LeiD.FrangC.LiC.WangM.LiuY.Perinatal Transmission of COVID-19 Associated"/>
 <result pre="We Worry?Clin Infect Dis226202010.1093/cid/ciaa226 105ShekC.C.NgP.C.FungG.P.G.ChengF.W.T.ChanP.K.S.PeirisM.Infants born to mothers with severe" exact="acute" post="respiratory syndromePediatrics1124200310.1542/peds.112.4.e254e254-e254 106LuQ.ShiY.Coronavirus disease (COVIDâ€�19) and neonate: what neonatologist"/>
 <result pre="Worry?Clin Infect Dis226202010.1093/cid/ciaa226 105ShekC.C.NgP.C.FungG.P.G.ChengF.W.T.ChanP.K.S.PeirisM.Infants born to mothers with severe acute" exact="respiratory" post="syndromePediatrics1124200310.1542/peds.112.4.e254e254-e254 106LuQ.ShiY.Coronavirus disease (COVIDâ€�19) and neonate: what neonatologist need"/>
 <result pre="105ShekC.C.NgP.C.FungG.P.G.ChengF.W.T.ChanP.K.S.PeirisM.Infants born to mothers with severe acute respiratory syndromePediatrics1124200310.1542/peds.112.4.e254e254-e254 106LuQ.ShiY.Coronavirus" exact="disease" post="(COVIDâ€�19) and neonate: what neonatologist need to knowJ Med"/>
 <result pre="role of peptides as potential therapeutic components for Middle East" exact="Respiratory" post="Syndrome (MERS): a reviewJ Infect Public Health111201891710.1016/j.jiph.2017.08.00928864360 108YaoT.T.QianJ.D.ZhuW.Y.WangY.WangG.Q.A systematic"/>
 <result pre="of peptides as potential therapeutic components for Middle East Respiratory" exact="Syndrome" post="(MERS): a reviewJ Infect Public Health111201891710.1016/j.jiph.2017.08.00928864360 108YaoT.T.QianJ.D.ZhuW.Y.WangY.WangG.Q.A systematic review"/>
 <result pre="and interferon therapy for critically ill patients with middle east" exact="respiratory" post="syndrome: a multicenter observational studyClin Infect Dis70920191837184410.1093/cid/ciz544 110MomattinH.Al-AliA.Y.Al-TawfiqJ.A.A Systematic"/>
 <result pre="of therapeutic agents for the treatment of the Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV)Travel Med Infect Dis30201991810.1016/j.tmaid.2019.06.01231252170 111WitE.FeldmannF.CroninJ.JordanR.OkumuraA.ThomasT.Prophylactic and therapeutic"/>
 <result pre="therapeutic agents for the treatment of the Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV)Travel Med Infect Dis30201991810.1016/j.tmaid.2019.06.01231252170 111WitE.FeldmannF.CroninJ.JordanR.OkumuraA.ThomasT.Prophylactic and therapeutic remdesivir"/>
 <result pre="Natl Acad Sci1171220206771677610.1073/pnas.192208311732054787 112MulanguS.DaveyR.T.MbayaO.T.ProschanM.MukadiD.ManzoM.L.A randomized, controlled trial of Ebola virus" exact="disease" post="therapeuticsN Engl J Med3812420192293230310.1056/NEJMoa191099331774950 113KimS.H.ChangS.Y.SungM.ParkJ.H.BinK.H.LeeH.Extensive viable Middle East respiratory"/>
 <result pre="virus disease therapeuticsN Engl J Med3812420192293230310.1056/NEJMoa191099331774950 113KimS.H.ChangS.Y.SungM.ParkJ.H.BinK.H.LeeH.Extensive viable Middle East" exact="respiratory" post="syndrome (MERS) coronavirus contamination in air and surrounding environment"/>
 <result pre="disease therapeuticsN Engl J Med3812420192293230310.1056/NEJMoa191099331774950 113KimS.H.ChangS.Y.SungM.ParkJ.H.BinK.H.LeeH.Extensive viable Middle East respiratory" exact="syndrome" post="(MERS) coronavirus contamination in air and surrounding environment in"/>
 <result pre="in MERS isolation wardsRev Infect Dis633201636336910.1093/cid/ciw239 114ArabiY.M.AsiriA.Y.AssiriA.M.JokhdarH.A.A.AlothmanA.BalkhyH.H.Treatment of Middle East" exact="respiratory" post="syndrome with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE"/>
 <result pre="MERS isolation wardsRev Infect Dis633201636336910.1093/cid/ciw239 114ArabiY.M.AsiriA.Y.AssiriA.M.JokhdarH.A.A.AlothmanA.BalkhyH.H.Treatment of Middle East respiratory" exact="syndrome" post="with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE trial):"/>
 <result pre="group sequential randomized controlled trialTrials21120201810.1186/s13063-019-3846-x31898511 115MomattinH.ZumlaA.MemoshZ.A.Al-TawfiqJ.A.Therapeutic options for Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV)â€&quot;possible lessons from a systematic review of"/>
 <result pre="sequential randomized controlled trialTrials21120201810.1186/s13063-019-3846-x31898511 115MomattinH.ZumlaA.MemoshZ.A.Al-TawfiqJ.A.Therapeutic options for Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV)â€&quot;possible lessons from a systematic review of SARS-CoV"/>
 <result pre="of the Binding Effect of Ritonavir, Lopinavir and Darunavir to" exact="Severe" post="Acute Respiratory Syndrome Coronavirus 2 ProteasesbioRxiv0131202092969510.1101/2020.01.31.929695 119Dieterich, DT. Method"/>
 <result pre="the Binding Effect of Ritonavir, Lopinavir and Darunavir to Severe" exact="Acute" post="Respiratory Syndrome Coronavirus 2 ProteasesbioRxiv0131202092969510.1101/2020.01.31.929695 119Dieterich, DT. Method of"/>
 <result pre="Binding Effect of Ritonavir, Lopinavir and Darunavir to Severe Acute" exact="Respiratory" post="Syndrome Coronavirus 2 ProteasesbioRxiv0131202092969510.1101/2020.01.31.929695 119Dieterich, DT. Method of treating"/>
 <result pre="Effect of Ritonavir, Lopinavir and Darunavir to Severe Acute Respiratory" exact="Syndrome" post="Coronavirus 2 ProteasesbioRxiv0131202092969510.1101/2020.01.31.929695 119Dieterich, DT. Method of treating anemia"/>
 <result pre="Respiratory Syndrome Coronavirus 2 ProteasesbioRxiv0131202092969510.1101/2020.01.31.929695 119Dieterich, DT. Method of treating" exact="anemia" post="caused by ribavirin treatment of hepatitis C using erythropoietin"/>
 <result pre="DT. Method of treating anemia caused by ribavirin treatment of" exact="hepatitis C" post="using erythropoietin alpha. U.S. Patent 2019; 10: 434-143. 120NystrÃ¶mK.WaldenstromJ.LaggingM.Ribavirin:"/>
 <result pre="by ribavirin treatment of hepatitis C using erythropoietin alpha. U.S." exact="Patent" post="2019; 10: 434-143. 120NystrÃ¶mK.WaldenstromJ.LaggingM.Ribavirin: pharmacology, multiple modes of action"/>
 <result pre="modes of action and possible future perspectivesFuture Virol143201915316010.2217/fvl-2018-0166 121SinclairS.M.JonesJ.K.MilerR.K.GreeneM.F.KwoP.Y.MaddreyW.C.The Ribavirin" exact="Pregnancy" post="Registry: an interim analysis of potential teratogenicity at the"/>
 <result pre="FDA-approved compound library identifies four small-molecule inhibitors of Middle East" exact="respiratory" post="syndrome coronavirus replication in cell cultureAntimicrob Agents Chemother5820144875488410.1128/AAC.03011-1424841269 124CongY.HartB.J.GrossR.ZhouH.FriemanM.BollingerL.MERS-CoV"/>
 <result pre="compound library identifies four small-molecule inhibitors of Middle East respiratory" exact="syndrome" post="coronavirus replication in cell cultureAntimicrob Agents Chemother5820144875488410.1128/AAC.03011-1424841269 124CongY.HartB.J.GrossR.ZhouH.FriemanM.BollingerL.MERS-CoV pathogenesis"/>
 <result pre="cellsPLoS One132018e01948610.1371/journal.pone.0194868 125MoY.FisherD.A review of treatment modalities for Middle East" exact="respiratory" post="syndromeJ Antimicrob Chemother711220163340335010.1093/jac/dkw33827585965 126GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.Hydroxychloroquine and azithromycin as a treatment"/>
 <result pre="pregnancyBull Soc Ophtalmol Fr6919694664675403305 130KaplanY.C.OzsarfatiJ.NickelC.KorenG.Reproductive outcomes following hydroxychloroquine use for" exact="autoimmune" post="diseases: a systematic review and metaanalysisBr J Clin Pharmacol815201683584810.1111/bcp.1287226700396"/>
 <result pre="J2020 132SperberK.HomC.ChaoC.P.ShapiroD.AshJ.Systematic review of hydroxychloroquine use in pregnant patients with" exact="autoimmune" post="diseasesPediatr Rheumatol Online J72009910.1186/1546-0096-7-919439078 133Al-TawfiqJ.A.MemishZ.A.Update on therapeutic options for"/>
 <result pre="Rheumatol Online J72009910.1186/1546-0096-7-919439078 133Al-TawfiqJ.A.MemishZ.A.Update on therapeutic options for Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV)Expert Rev Anti Infect Ther153201726927510.1080/14787210.2017.127171227937060 134ChannappanavarR.FehrA.R.ZhengJ.Wohljord-LenaneC.AbrahanteJ.E.MackM.IFN-I response"/>
 <result pre="Online J72009910.1186/1546-0096-7-919439078 133Al-TawfiqJ.A.MemishZ.A.Update on therapeutic options for Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV)Expert Rev Anti Infect Ther153201726927510.1080/14787210.2017.127171227937060 134ChannappanavarR.FehrA.R.ZhengJ.Wohljord-LenaneC.AbrahanteJ.E.MackM.IFN-I response timing"/>
 <result pre="134ChannappanavarR.FehrA.R.ZhengJ.Wohljord-LenaneC.AbrahanteJ.E.MackM.IFN-I response timing relative to virus replication determines MERS coronavirus" exact="infection" post="outcomesJ Clin Invest1299201910.1172/JCI126363 135HabibA.M.G.AliM.A.E.ZouaouiB.R.TahaM.A.H.MohammedB.S.SaquibN.Clinical outcomes among hospital patients with"/>
 <result pre="Clin Invest1299201910.1172/JCI126363 135HabibA.M.G.AliM.A.E.ZouaouiB.R.TahaM.A.H.MohammedB.S.SaquibN.Clinical outcomes among hospital patients with Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) infectionBMC Infect Dis19120191610.1186/s12879-019-4555-530606108 136LokugamageK.G.HageA.SchindewolfC.RajsbaumR.MenacheryV.SARS-CoV-2 sensitive to"/>
 <result pre="Invest1299201910.1172/JCI126363 135HabibA.M.G.AliM.A.E.ZouaouiB.R.TahaM.A.H.MohammedB.S.SaquibN.Clinical outcomes among hospital patients with Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) infectionBMC Infect Dis19120191610.1186/s12879-019-4555-530606108 136LokugamageK.G.HageA.SchindewolfC.RajsbaumR.MenacheryV.SARS-CoV-2 sensitive to type"/>
 <result pre="respiratory syndrome coronavirus (MERS-CoV) infectionBMC Infect Dis19120191610.1186/s12879-019-4555-530606108 136LokugamageK.G.HageA.SchindewolfC.RajsbaumR.MenacheryV.SARS-CoV-2 sensitive to" exact="type I" post="interferon pretreatmentbioRxiv0307202098226410.1101/2020.03.07.982264 137YazdaniB.P.MatokI.GarciaB.F.KorenG.A systematic review of the fetal safety"/>
 <result pre="the fetal safety of interferon alphaReprod Toxicol33201226526810.1016/j.reprotox.2011.11.00322200624 138SperaA.M.EldinT.K.TosoneG.OrlandoR.Antiviral therapy for" exact="hepatitis" post="C: Has anything changed for pregnant/lactating women?World J Hepatol812201655710.4254/wjh.v8.i12.55727134703"/>
 <result pre="Has anything changed for pregnant/lactating women?World J Hepatol812201655710.4254/wjh.v8.i12.55727134703 139Peckâ€�RadosavljevicM.Thrombocytopenia in" exact="chronic" post="liver diseaseLiver Int376201777879310.1111/liv.1331727860293 140BalsatM.EtienneM.ElhamriM.HayetteS.SallesG.ThomasX.Successful pregnancies in patients with BCRâ€�ABLâ€�positive"/>
 <result pre="J Biol Macromol126201929129710.1016/j.ijbiomac.2018.12.18830583005 142ZhouY.LuK.PfefferleS.BertramS.GlowackaI.DrostenC.A single asparagine-linked glycosylation site of the" exact="Severe" post="Acute Respiratory Syndrome coronavirus spike glycoprotein facilitates inhibition by"/>
 <result pre="Biol Macromol126201929129710.1016/j.ijbiomac.2018.12.18830583005 142ZhouY.LuK.PfefferleS.BertramS.GlowackaI.DrostenC.A single asparagine-linked glycosylation site of the Severe" exact="Acute" post="Respiratory Syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding"/>
 <result pre="Macromol126201929129710.1016/j.ijbiomac.2018.12.18830583005 142ZhouY.LuK.PfefferleS.BertramS.GlowackaI.DrostenC.A single asparagine-linked glycosylation site of the Severe Acute" exact="Respiratory" post="Syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin"/>
 <result pre="142ZhouY.LuK.PfefferleS.BertramS.GlowackaI.DrostenC.A single asparagine-linked glycosylation site of the Severe Acute Respiratory" exact="Syndrome" post="coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through"/>
 <result pre="mannose-binding lectin through multiple mechanismsJ Virology8420108753876410.1128/JVI.00554-1020573835 143IpW.K.E.ChanK.H.LawH.K.W.TsoG.H.W.KongE.K.P.WongW.H.S.Mannose-binding lectin in severe" exact="acute" post="respiratory syndrome coronavirus infectionJ Infect Dis1911020051697170410.1086/42963115838797 144ZumlaA.ChanJ.F.W.AzharE.I.HuiD.S.C.YuenK.Y.Coronaviruses - drug"/>
 <result pre="lectin through multiple mechanismsJ Virology8420108753876410.1128/JVI.00554-1020573835 143IpW.K.E.ChanK.H.LawH.K.W.TsoG.H.W.KongE.K.P.WongW.H.S.Mannose-binding lectin in severe acute" exact="respiratory" post="syndrome coronavirus infectionJ Infect Dis1911020051697170410.1086/42963115838797 144ZumlaA.ChanJ.F.W.AzharE.I.HuiD.S.C.YuenK.Y.Coronaviruses - drug discovery"/>
 <result pre="through multiple mechanismsJ Virology8420108753876410.1128/JVI.00554-1020573835 143IpW.K.E.ChanK.H.LawH.K.W.TsoG.H.W.KongE.K.P.WongW.H.S.Mannose-binding lectin in severe acute respiratory" exact="syndrome" post="coronavirus infectionJ Infect Dis1911020051697170410.1086/42963115838797 144ZumlaA.ChanJ.F.W.AzharE.I.HuiD.S.C.YuenK.Y.Coronaviruses - drug discovery and"/>
 <result pre="145HaagmansB.L.Van Den BrandJ.M.RajV.S.VolzA.WohkseinP.SmitsS.L.An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV" exact="infection" post="in dromedary camelsScience35162682016778110.1126/science.aad128326678878"/>
</results>
